# Darbepoetin Administration to Preterm Infants

> **NCT00334737** · PHASE2 · COMPLETED · sponsor: **University of New Mexico** · enrollment: 102 (actual)

## Conditions studied

- Infant, Newborn

## Interventions

- **DRUG:** Darbepoetin Alfa Injection
- **DRUG:** erythropoietin alfa injection
- **DRUG:** sham injection

## Key facts

- **NCT ID:** NCT00334737
- **Lead sponsor:** University of New Mexico
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2013-12
- **Final completion:** 2014-06
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2019-02-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00334737

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00334737, "Darbepoetin Administration to Preterm Infants". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00334737. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*